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AGE   Advanced glycation end products 
AKT   Protein kinase B 
AUC  Area under the curve 
BM    Basal membrane 
BRAF   Rapidly Accelerated Fibrosarcoma; a serine–threonine protein 
kinase in the RAS-RAF-MEK-ERK signaling cascade 
CCND1 Cyclin D1 
CDK   Cyclin-dependent kinase 
CDKi  Cyclin-dependent kinase inhibitor 
COLI   Collagen I 
COLIV  Collagen IV 
CTL  Cytotoxic T-lymphocyte 
DDR  DNA damage response 
EC50  Half maximal effective concentration 
ECM   Extracellular matrix 
EGF    Epidermal Growth Factor 
ER  Estrogen receptor 
ERK   Extracellular signal-regulated kinase 
FAK  Focal adhesion kinase 
FN   Fibronectin 
GAB1  GRB2-associated-binding protein 1 – adaptor protein 
GRB2   Growth factor receptor-bound protein 2 – adaptor protein 
GTP    Guanosine-5'-triphosphate 
HEK293 Human Embryonic Kidney cells 
HER2   Human Epidermal Growth Factor Receptor2 / ERBB2 / Neu 
HIF-1  Hypoxia inducible factor 1 
HMEC Human mammary epithelial cell 
LAM     Laminin 
LEP  Luminal epithelial cells 
LOX   Lysyl Oxidase  
MAPK   Mitogen-Activated Protein Kinase 
MCF10  Michigan Cancer Foundation-10 human breast cancer cell line 
MEP   Myoepithelial cells 
MMP  Matrix Metalloproteinases 
mTORC1 Mechanistic Target of Rapamycin Complex 1 
OIS   Oncogene-induced senescence 
PI3K   Phosphoinositide-3 kinase 
PIP   Phosphatidylinositol phosphate 
PKC   Protein kinase C 
RB    Retinoblastoma Protein 
pre-stasis Cells in a growing state before stasis 
p16  Cyclin Dependent Kinase Inhibitor 2A, also abbr. CDKN2A   
p21        Cyclin Dependent Kinase Inhibitor p21 
PFA  Paraformaldehyde 
PBS  Phosphate buffered saline 
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Rac  a GTPase of the Rho family 
Ras    Short for Rat Sarcoma – a small G protein which binds to the 
cytoplasmic domain of RTK 
Rho  a small G protein which regulate the formation of stress fibers 
RTK    Receptor Tyrosine Kinase 
RGD motif Arg-Gly-Asp tripeptide 
SASP   Senescence- Associated Secretory Phenotype 
SHP2   non-receptor tyrosine phosphatase containing Src Homology 2 
domains 
Shc  Short for Src homology and collagen (Shc) family of adaptor 
proteins which function as a node for signaling proteins 
Sos  Son of sevenless homolog – adaptor protein 
Src  Short for Sarcoma – a non-receptor tyrosine kinase, a proto 
oncogene 
TERT  Telomerase Reverse transcriptase 
TDLU   Terminal Ductal Lobular Unit 
TGF-β Transforming Growth Factor-b 
TP53  Tumour protein 53 = a tumour suppressor protein 
VN    Vitronectin 
y  years 
 
Glossary 
Agonescence   Senescence caused by telomere shortening 
Agonist A molecule which binds and stimulates the activity of a 
receptor 
Anoikis Cell death due to lack of cell anchorage to the extracellular 
matrix or neighbouring cells. 
Antagonist  A molecule which binds and blocks the activity of a receptor 
Apoptosis   Programmed cell death, as opposed to necrosis 
Cell Strain Finite life cells with have only gone through a limited 
number of population doublings.  
Crisis           Telomer shortening leading to persistent growth arrest and                                
 apoptosis 
Desmosome Junctional protein complex that facilitates adhesion between 
epithelial cells 
Finite life  The opposite of immortal life 
Hemidesmosome Junctional protein complex that facilitates adhesion                                            
.                            between an epithelial cell and the surrounding extracellular                      
..                           matrix 
Lineage A group of cells descending from a common ancestor 
Senescence Living state of cell involving functional metabolism, but no 
cell division 
Slug  Transcription factor known to induce EMT 





Age is the greatest risk factor for developing cancer. Two-thirds of cancer 
diagnoses occur in people over the age of 65. This increased vulnerability to 
tumourigenesis is attributed to intrinsic cellular changes, in particular the age-
related telomere shortening and the accumulation of mutations over time and. 
We propose that extrinsic factors comprising age-related alterations in the 
tissue microenvironment are also important in cancer development. We sought 
to elucidate how the microenvironmental affects cells, and how this is related 
to cancer development. This knowledge can be utilized to improve prevention, 
diagnosis and treatment of cancer in our ageing population.  
 
Cellular function is coordinated by microenvironmental factors such as growth 
factors, cytokines as well as extracellular matrix proteins. Soluble factor-
mediated signal transduction is strongly influenced by microenvironmental 
context. To allow single cell level measurement of the microenvironmental 
contextual effect on cell signaling, we developed a novel flow cytometry 
method: microsphere cytometry. Single normal or neoplastic cells were 
adhered to uniform microspheres that display mimetic-microenvironments 
comprising surface combinations of extracellular matrix (ECM) in the presence 
of soluble agonists or antagonists. Temporal signaling responses were 
measured with fluorophore-conjugated antibodies that recognize response-
dependent epitopes by multiparametric flow cytometry. Using this approach, 
we demonstrated that microenvironment-mimetic combinations of growth 
factors and extracellular matrix proteins generate distinct cellular signaling 
signatures from normal and patient biopsy-derived neoplastic cells. 
 
We asked whether the ageing process affects how human mammary epithelial 
cells (HMEC) respond to microenvironmental signals, and if this altered 
response results in increased susceptibility to oncogenic transformation. Using 
microsphere cytometry we analyzed age-dependent changes in human 
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mammary myoepithelial and luminal epithelial cells exposed to different ECM 
and growth factors. We found that ECM–mediated MAP kinase and PI3K 
pathway activation levels in HMEC are attenuated with age, and that the 
diminished signaling magnitude in HMEC from ageing women correlated with 
reduced probability of activating oncogene-induced senescence.  
 
Our results suggest that attenuated cell signaling response may reduce the 
likelihood of activating oncogene induced senescence, for cells in ageing 
women. We hypothesize this is the result of age-related changes to the 
microenvironment that support age-emergent cellular phenotypes with 
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Humans are subject to increased mortality with age. The main theories of 
cellular ageing state that cell longevity is intrinsically programmed by certain 
genes (Werfel 2015) and is extrinsically determined by extracellular cues that 
determine when these genes are expressed (Kirkwood & Wellcome 2005). 
Hence in order to understand how ageing affects cells we must define  
the nature of these extrinsic factors and how they affect cellular functions. In 
particular, age is strongly correlated with increased cancer risk (White et al. 
2014). Of all diagnosed cancers in Norway, 87% occur in people over the age 
of 50 (Kreftregisteret 2016). Congruently, post-menopausal women are more prone 
to breast cancer than younger women. The increased frequency of breast cancer 
with age is likely due to interactions between acquired gene mutations and age-
dependent changes in the breast tissue microenvironment that affect mammary 
epithelial cells. In this thesis we address how ageing affects human mammary 
epithelial cell responses to microenvironmental signals, and how this corresponds to 
age-related cancer susceptibility.   
 
1.1 Mammary gland 
In this study we have used low passage primary human epithelial mammary 
cells (HMEC). The mammary gland and the ovaries are of particular interest as 
they go through monthly gland involution and apoptosis, followed by 
regeneration which involve a monthly mobilization of stem cells throughout 
fertile years followed by a forced retirement upon menopause (Ingthorsson et 
al. 2016; Rønnov-Jessen et al. 1996). Moreover, breast cancer is the most 
common female cancer worldwide, and healthy tissues are readily attainable 
from women who undergo reduction mammoplasty. We chose to study human 
mammary epithelial cells to address why cells in an older environment are 
more prone to develop into cancer cells.  
 
The milk secreting compartment of the mammary gland – the parenchyme 
consists of myoepithelial and luminal epithelial cells (Fig.1). There is accumu-
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mammary epithelial lineages, but a quiescent stem cell subset is yet to be 
found. Only when there is a consensus on optimal subset markers can this be 
resolved (Visvader & Clevers 2016; Santagata & Thakkar 2014; Lim et al. 
2009). The progenitor cells coexpress luminal and myoepithelial markers, 
EpCAM, CD49f, Cytokeratin 19 and 14, while the resulting myoepithelial cells 
are CD49f / CD14 positive, and luminal cells EpCam / CD19 positive (Spike et 
al. 2012; Stingl et al. 2001). The myoepithelial-luminal bilayer forms a hollow 
acinus inside which milk is produced. Luminal cells produce milk and secrete 
this into the 
lumen of the 
acinus. 
Myoepithelial 
cells wrap around 
the acinus, and 
contract to 
squeeze milk out 
through the ducts.  
 
Fig.2 Basal membrane 
construction. Adapted 
from (Dunsmore 2008) 




Myoepithelial cells are the main source of laminin α1 which is deposited along 
the apicobasal axis between the cell layers (Gudjonsson et al. 2005). Luminal 
cells attach to each other and to myoepithelial cells via desmosomes, and to 
the extracellular matrix (ECM) by hemidesmosomes.  Maintenance of 
hemidesmosome distribution  in the cell membrane is crucial for cell polarity, 
and consequently to function (Adriance et al. 2005). The laminin binding 
integrin α6β4 regulates hemidesmosome assembly and therefore the polarity of 
both luminal and myoepithelial cells (Gudjonsson et al. 2002). 
 
Epithelial cells in healthy mammary tissue are separated from the stroma by a 
basal membrane. It comprises the ECM proteins laminin and collagen IV 
(Fig.2). Laminin maintains cell differentiation and supresses growth (Spencer 
et al. 2007). Collagen IV keeps cell EGF signaling levels to a minimum (Ertsås 
et al. 2017) by inhibition through phosphatase SHP2 (Mattila et al. 2008; Deb 
et al. 1998). Myoepithelial cells orient one side towards the basal membrane, 
and the opposite side towards the luminal cells. Myoepithelial cells produce 
the ECM proteins and the cytokines 
necessary to instruct luminal differentiation 
and retain the distribution of integrin α6β4 to 
the basolateral sides of luminal cells 
(Runswick et al. 2001; Deugnier et al. 2002). 
Groups of acini forms lobules surrounded by 
stroma (Fig.3). The breast stroma, which 
makes up 80% of the breast, contains matrix 
proteins, immune cells, fibroblasts, 
adipocytes, nerves and blood vessels 
(Rønnov-Jessen et al. 1996). The lobules 
proliferate, differentiate and then go 
through apoptosis with every menstrual 
cycle, and ultimately degenerate post-
menopause (Milanese et al. 2006).  
Fig.3: Illustration of the human breast with ducts 
and lobules consisting of epithelial bilayers. 
Adapted from (Mortazavi et al. 2015) with 




1.2  Mammary Microenvironment  
 The fate of the progenitor mammary cell, whether it turns into a luminal or 
myoepithelial cell, is determined by a combination of soluble signals from other 
cells, as well as the surrounding extracellular matrix which together make up 
the microenvironment (LaBarge et al. 2009; Lui et al. 2012; Lim et al. 2009; 
Miyano et al. 2017). The sensing of the cellular microenvironment comprises 
cell-cell and cell-ECM interactions, as well as interactions with soluble and 
tensile factors (Glukhova & Streuli 2013). The microenvironment has 1) 
chemical properties conveyed through the ligand-receptor transition; 2) 
physical properties including the stiffness and elasticity of the tissue 
transferred through mechanoreceptors being pushed and pulled and 3) 
architectural properties which involve the distribution of cell surface proteins on 
particular sides of the cell, in polar patterns (Fig.4) (Marinkovic et al. 2016; Lee 
et al. 2015). The physical properties of the microenvironment that change with 
age are conveyed through mechanoreceptors such as integrins, they bind 
ECM proteins and translate the signal to the cell nucleus. Gene expression is 
consequently modified by the microenvironment, and the cell in turn modifies 
the microenvironment in a case of dynamic reciprocity (Bissell et al. 1982). 
 
Fig.4: Fibrous extracellular 
matrix proteins (M) stretching 
around cells (Schedin & Keely 
2011). With permission from 






1.2.1 Extracellular Matrix Proteins (ECM proteins) 
Fig.5: Extracellular matrix located on the outside of the cell membrane. Integrins, the ECM receptors 
are located in the membrane (Wiley 1999).  With permission from John Wiley and Son. 
 
The outer layer of the bilayer comprising myoepithelial and luminal cells, is in 
direct contact with the basal membrane, which consists of the matrix proteins  
laminin and collagen IV (Fig.5) (Fata et al. 2003). Other structural proteins 
include proteoglycans of the type heparan sulfate (Bonnans et al. 2014). 
Fibroblasts deposit collagen I outside of the basal membrane, in the interstitial 
area between the ducts and lobules. The interstitial tissue is also rich in 
collagen III, tenascin and proteoglycans (Bonnans et al. 2014).  
 
Collagen 
The matrix protein collagen is the most abundant protein in the body. There 
are at least 28 types, while the three types I, II and III make up the 80-90% of 
all collagens in the human body, and comprise the major part of bones and 
cartilage (Ricard-Blum 2011; Snedeker & Gautieri 2014). It contributes during 
wound healing, together with fibronectin, to build a rigid matrix that supports 
regrowth of cells (Midwood et al. 2004). When lysyl oxidase form cross links 
between neighbouring collagen I helices it creates a stiffer collagen fibril (Erler 
et al. 2006). Stiffer tissue tensile force in the interlobular stroma exert influence 
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on cell fate by activating integrin receptors in the underlying epithelium. 
Persistent high tensile force result in persistent integrin activation. The 
crosslinked collagen cluster together integrin α2β1 among others, and form 
focal adhesions which trigger intracellular adaptors RhoGTPase and ROCK to 
increase intracellular stiffness and transcription of genes involved in 
proliferation, survival and cell motility (Mariotti et al. 2001; Morse, Brahme & D. 
A. Calderwood 2014; Sieg et al. 2000). 
 
Fibronectin 
The matrix protein fibronectin promotes proliferation and invasive behavior, 
while preventing differentiation from progenitor state into a functional cell 
(Roman et al. 2010). Normal interstitial fibronectin turnover in healthy 
mammary tissue is low, as detected by immunohistochemistry (Williams et al. 
2008). The protein is degraded in the final steps of wound healing allowing 
collagen I deposition. The main role of fibronectin is during inflammation, 
embryonic development (Erler & Weaver 2009), and in the proliferative phase 
of the menstrual cycle (Williams et al. 2008),(Huveneers & Danen 2009), while 
fully developed mammary acini lose structure and polarity in the presence of 
persistent amounts of fibronectin (Williams et al. 2008). Proliferative signals, 
combined with the suppression of differentiation coming from persistent 
fibronectin in the tissue, prompt cells into becoming tumourigenic. 
 
Laminin 
The matrix protein laminin, induces cell differentiation into luminal and 
myoepithelial cells, and is responsible for maintaining the phenotypes of 
epithelial cells residing in intact tissue (Fig.6) (Spencer et al. 2010; Streuli et 
al. 1995). Laminin exogenically added to mammary epithelial cells in vitro 
restricts their production of fibronectin (Williams et al. 2008) , as laminin 
opposes the effect of fibronectin. In this manner laminin located in the basal 
membrane has a tumour-suppressive function. Cells remain differentiated and 
retain their function provided that the basal membrane is intact.  
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A major producer of ECM proteins are fibroblasts. Fibroblasts may also be the 
source of myofibroblasts, which appear in metastatic and inflammatory 
circumstances. The proposed theory is that fibroblasts morph into 
myofibroblast in these settings (Ueha et al. 2012). Finally, physical cues from 
the ECM, such as stiffness and topology, are as important as the biochemical 
component of soluble and fibrous ligands (Kass et al. 2007; Pouwels et al. 
2012).  We see potential for great variations in the breast microenvironment 
with increasing age and whenever homeostasis is challenged during the 
monthly hormonal cycles. We question how these variations are translated into 
gene expression in the residing cells of the tissue. 
 
 
Fig.6: 2D growth of mammary fibrotic cell line MCF10 on collagen I, fibronectin and laminin, illustrates 




1.3 Integrins  
The cellular microenvironment 
imparts numerous physical 
forces such as stress applied 
parallel to the surface of the 
cell, compression of the cell, 
and pulling leading to 
expansion of the cell (Butcher 
et al. 2009). Cells demonstrate 
mechano-reciprocity to 
these inputs through 
mechanoreceptors such as 
Collagen I              Fibronectin             Laminin 
Fig.7: Integrin dimers are composed of an α and a β subunit which is 
inactive in the folded confirmation Several intracellular modulators 
are recruited to the intracellular moiety when the integrin is in the 
active configuration (Gilcrease 2007). With permission from Elsevier.  
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integrins (Hagios et al. 1998). Cell-cell or cell-ECM interactions are nanoscale 
forces that influence cell function through actomyosin contractility and actin 
dynamics (Butcher et al. 2009). Integrins are dimeric transmembrane proteins 
(α and β subunits) with an extracellular domain that binds ECM proteins, a 
transmembrane domain and an intracellular tail that is phosphorylated at either 
tyrosine (Tyr), serine (Ser) or threonine (Thr) by recruited kinases (Fig.7).  
 
1.3.1 Ligand specificity of integrins 
The level and type of integrins 
expressed, their distribution on 
the cell surface, as well as the 
type of ECM dominating the 
surrounding matrix will determine 
response. Fibronectin has affinity 
to α5β1 and αVβ3 , collagen I bind 
integrins α2β1 and α3β1 (Hynes et 
al. 2011) while laminin binds to  
α6β1, α3β1 and has exclusive 
affinity to α6β4 (Mercurio et al. 
2001) (Fig. 8).           
 
1.3.2 Upstream and downstream of the integrin     
Most receptors enter an active state upon ligand binding (Wegener & 
Campbell 2008; Paszek et al. 2009; Elosegui-Artola et al. 2014). However, 
integrin receptors are allosteric enzymes, and ligand affinity is influenced                              
by the intracellular environment, to the extent that integrin activation can be 
initiated from both outside-in and inside-out, in a feed forward loop (Fig.9). 
Fig.8: Integrin subunits (Hynes et al. 2011). With 






α and can be 
released from 
the inside by 
Talin and Kindlin 
located on the 
inside leaflet of 
the plasma 
membrane. The 
release of subunit β from the 
clasp of subunit α make space 
around the extracellular domain for a ligand to bind (Pouwels et al. 2012; 
Legate et al. 2009).  
 
Actin contraction on the inside increases affinity of the integrins on the outside 
and thereby increase stiffness around the cell (Trusolino et al. 2000). 
Independent of whether the integrin is activated by ligand binding or by the 
recruitment of intracellular adaptor talin or kindlin, the resulting adhesome 
complex comprise kinases, phosphatases, scaffold proteins, and signaling 
proteins such as Src, FAK, paxillin, Shc, Syk, Shr and Fyn among others (Fig. 
9, Fig.12). All are involved in migration and motility (Roberts et al. 2002; 
Huveneers & Danen 2009; Legate et al. 2009) (Fig.12). The intracellular 
integrin binding proteins secondly activate nearby integrins and the 
intracellular moiety of nearby growth factor receptors.  Vacant binding domains 
on the fibrous ECM adhere, and sequentially immobilize additional integrins 
into a cluster (Legate et al. 2009; Geiger & Yamada 2011; Morse, Brahme & 
D. A. Calderwood 2014). The cascade of assembled integrins and signaling 
proteins eventually mature into focal adhesions that integrate the cytoskeleton 
into the equation (Welf et al. 2012; Bonnans et al. 2014). FAK phosphorylated 
Fig.9: Integrin clusters (Miranti & Brugge 2002). With 
permission from Nature Publishing Group 
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at Tyr397 initiates cytoskeletal contraction and link focal adhesions to actin 
fibres of the cytoskeleton via paxillin and tensin (Morse, Brahme & D. A. 
Calderwood 2014) (Fig.12). Focal adhesions regulate cell shape and fate 
through interactions between the ECM on the outside and actin linker proteins 
on the inside, using RhoGTPases to remodel of the cytoskeleton (Riento & 
Ridley 2003; Kass et al. 2007). The Rho/Rock pathway triggers Cdc42 and 
Rac1 responsible for forming actin rich protrusions such as filopodia that 
induce random migration of cells in different directions, or lamellipodia which 
induce persistent cell migration of all cells in a sheet. The cell moves forward 
by the help of actin contractions, releasing integrin attachments at the rear end 
(Sieg et al. 2000). The result is cell motility and migration (Fig.12). 
 
1.3.3 Integrin Interaction with growth factor (GF) receptors  
Integrin induced signals provide an influential context for growth factor 
receptor- and G protein coupled receptor-induced signaling to occur within 
(Harburger & Calderwood 2009; Levental et al. 2009). Integrins fine-tune 
ongoing signaling (Morse, Brahme & D. A. Calderwood 2014), in part by 
increasing the plasma membrane proximity of signaling proteins. The 
intracellular moieties of integrins do not have their own kinase activity, but 
recruit kinases to sites that can be phosporylated. The recruited kinases 
phosphorylate residues on the integrins themselves, as well as nearby 
intracellular moieties of growth factor receptors.  The kinase of the growth 
factor receptor autophosphorylate and activate downstream signaling, in 
particular the MAPK and PI3K pathways. Interestingly, integrin recruited 
kinases target other residues than the intrinsic kinase activity of the growth 
receptor,  and therefore induce different downstream signaling compared to 
the growth factor alone (Kumar 1998; Balanis et al. 2011; Cabodi et al. 2004; 
Streuli & Akhtar 2009).  
 
The growth factor receptor-integrin interaction is demonstrated by EGF 
stimulation of adherent versus suspension HEK293 (human embryonic kidney) 
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cells. Cells in suspension 
do not show changes in 
EGFR phosphorylation 
upon EGF stimulation. In 
contrast, cells adhered to 
a surface coated with 
fibronectin or laminin give 
a strong pEGFR response  
(Yarwood & Woodgett 
2001) (Fig.10). This way 
ECM enhances growth 
factor signaling and 
modifies the requirement of 
cytokine binding to achieve 
receptor activation (Erler & 
Weaver 2009; Levental et al. 
2009). The threshold to trigger receptor activation is lower when certain sites 
are already phosphorylated by help of adjacent integrins, allowing the 
recruitment of necessary kinases to phosphorylate remaining residues on the 
receptor. 
 
Fig.10 Phospho-levels of EGFR in HEK293 cells 
cultured on plastic (poly-Lysine), on fibronectin and 
on laminin, with or without EGF stimulation 
(Yarwood & Woodgett 2001). With permission from 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.3.4 Integrins can trigger GF Receptors independent of GF 
Integrins can activate growth factor receptors in a ligand independent fashion 
(Fig.11). Balanis et al. demonstrated in murine mammary cells that EGFR was 
not activated through its ligand EGF, but rather through the activation of 
fibronectin-binding integrins αVβ3, or α5β1 that lead to phosphorylation of 
Tyr992, Tyr1068, Tyr1173 and Tyr845 on the intracellular moiety of EGFR 
(Balanis et al. 2011). Adding EGF to the EGFR did not affect EGFR phospho-
level, but affected the phospho-level of the intracellular moiety of β4 (Mariotti et 



















1.3.5 Crosstalk between MAPK and PI3K pathways  
Crosstalk between the MAPK and PI3K pathways downstream of receptor 
tyrosin kinase (RTK) can alter the outcome of receptor activation. There are 
both positive and negative feedback interactions between signaling proteins in 
these pathways (Ref. 7 & 16 in Fig.12) that fine tune signal transduction in 
response to signal intensity or contextual factors (Ref. 12 & 17 in Fig.12). An 
example is recruitment of Shc–GRB2–SOS complexes that activate the RAS/ 
MAPK pathway. This attenuate PI3K pathway activation when EGFR 
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stimulation increases. In fact, EGFR is found to be a potent activator of ERK, 
but a weak activator of the PI3K pathway (Kolch et al. 2015). EGFR has 
various ligands that generate different signals. When HGF binds to EGFR it 
triggers a different crosstalk pattern down-stream compared to when EGF 
binds. This is because HGF stimulation of EGFR does not initiate the tyrosine 
phosphatase SHP2 (Fig.12). SHP2 
recruitment represents a negative 
feedback on the GAB1-PI3K pathway, and 
a positive feedback on the Ras-MAPK 
pathway (Yu et al. 2002). The MAPK 
substrate ERK5 is suggested to be 
responsible for SHP2 recruitment to GAB1 
(Yu et al. 2002; Wöhrle et al. 2009). AKT 
activation is therefore retained low, while 
ERK remains high (Fig.12). Variations in 
signaling as a function of time may 
however not involve feedback at all, but 
rather diverging downstream pathways, 
acting on substrates in a series of different 
time points.  
 
An example is ERK which is phosphorylated after 5 minutes of growth factor 
stimulation, while AKT is not phosphorylated for another 45 to 90 minutes 
(Mendoza, Emrah Er, and Blenis 2011a). Crosstalk between MAPK and PI3K 
pathways is regulated by which and how many residues  on RTK are 
phosphorylated upon stimulation (Fig.13). Signaling thresholds dictate whether 
feedback is positive, negative or diverging.  pERK is involved in more negative 
feedback loops -back on itself and from other effectors - than pAKT (Birtwistle 
et al. 2007; Kumar et al. 2007). If distribution, rigidity and composition of the 
ECM changes due to age or pathology as described in section 1.2 will this 
 
MAP Kinase           PI3 Kinase 
   pathway                 pathway 
 
Proliferative         Anti-apoptotic 
   signaling             signaling  
Crosstalk  
Fig.13: Crosstalk between pathways 
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affect mechano- and growth factor signalling in cells residing in the tissue, and 
secondly will this effect be sufficiently long term to influence cell phenotype? 
 
1.4 Ageing in the mammary gland 
Ageing at the physiological level is a gradual reduction of  tissue homeostatic 
function (Snedeker & Gautieri 2014). This is the result of changes in cellular 














1.4.1 Extrinsic factors that promote ageing   
The altered microenvironment potentiates the ageing process by supporting 
altered cellular phenotypes. The outcome is a reduction of cancer protective 
mechanisms including tumour-suppressive functions of the microenvironment 
(Mina J Bissell et al. 2002). How does these systemic changes of hormonal 
and structural nature (Table 1) trickle down to the microenvironment and into 
individual cells, to induce such long-term effects as cancer susceptibility? 
Fig.14: Hallmarks of ageing. A summary of reasons for ageing, physiological and cellular (López-




Fibrosis is an excess of fibrous connective tissue in an organ previously populated 
with cells (Zeisberg & Kalluri 2013).  
Fibrosis is considered an initiating stage of cancer development (Cox & Erler 
2014). Mammography measures tissue density in the breast, and indicates the 
level of fibrosis.  
There is increased collagen I deposition and increased rigidity of the tissue.  
A stiffer microenvironment transforms interstitial fibroblasts into myofibroblasts 
(Bogatkevich 2015), and promote further secretion of collagen I in a feed forward 
loop  (López-Nouoa & Nieto 2009). 
Adipocytes replace epithelial cells 
Invading adipocytes take over the space previously filled with epithelial cells 
(Machida & Nakadate 2015). 
Reactive oxygen species (ROS) 
Mitochondrial deterioration lead to reactive oxygen species ROS, which attack both 
DNA and proteins. Aberrant function of enzymes that deal with carcinogens in older 
people make them more sensitive to carcinogens (Hoffe 2012). 
 
Collagen cross linking 
Despite the resulting general decrease in breast density with age, individual loci 
have increased stiffness where collagen I is increasingly crosslinked.  
Lysyl oxidase (LOX) activity introduces crosslinks within collagen I fibrils, which 
increase rigidity and linearization (Egeblad et al. 2010).  
Accumulation of linearized collagen I with age allows more efficient cell migration, 
involving intensified integrin activation (Condeelis & Segall 2003)  
Loss of immune function 
Immune surveillance is less efficient in detecting and removing neoplastic cells. 
Simultaneously, inflammation is more frequent and more likely to become chronic 
giving rise to “the wound that never heals” (Dvorak 2016). 
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Disintegration of the Basal Membrane 
Basal membrane experiences proteolytic degradation due to MMPs and 
inflammatory factors derived from fibroblasts and macrophages (Nguyen-Ngoc et 
al. 2012; Benz 2008; Milanese et al. 2006; Ueha et al. 2012). It becomes thinner 
and discontinuous. 
Epithelial cells are exposed to collagen I in the interstitium. This is interpreted by 
the epithelia as a wound, and wound healing is initialized (Xue & Jackson 2015; 
Midwood et al. 2004).  
Luminal cells cannot maintain differentiation when laminin is lacking in their 
microenvironment. 
Signaling from integrin receptors is initiated by the clustering of receptors, which 
explains why the epitopes need to occur in solid state, close to each other. This 
requirement is only fulfilled when ECM fibres are present in a matrix. Disintegration 
of the basal membrane result in fewer solid state ligands present to keep the 
integrin expression and localization in check (Sager 1993).  
 
Table 1: tissue homeostatic function deteriorates with age 
 
1.4.2 Intrinsic factors that promote ageing 
Intrinsically determined ageing is genetically programmed, occurring 
independent of microenvironmental changes. It is exemplified by senescence 
which is the current prevailing theory of ageing (Childs et al. 2015). Senescent 
cells are in proliferative arrest, but remain metabolically active. They may 
infrequently revert to a proliferative state, apoptose or persist as a phenotype 
which creates an inflammatory microenvironment around themselves by 
secreting given cytokines (Kolch et al. 2015).  Senescence links hyperplastic 
pathologies and ageing (Campisi 2013). The tumour suppressor TP53 protects 





1.4.2.1   Senescence  
Senescence occurs in 
response to excessive 
extracellular or 
intracellular stress 




following multiple cell 
divisions, exposure to 
oxidants, mitochondrial                                              
deterioration or disruption of 
chromatin organization. 
Alternatively senescence may be due to extrinsic exposures such as: DNA 
damaging chemotherapies, γ-irradiation and UVB light (Campisi & d’Adda di 
Fagagna 2007; van Deursen 2014; Hayflick & Moorhead 1961; Hornsby 2011).  
 
Oncogenes causing inappropriate mitogen signaling can also lead to 
senescence. The fraction of senescent fibroblasts in humans have been found 
to increase with age (Faragher et al. 2017). A higher number of senescent 
cells can be due to chronic inflammation, a higher fraction of persistent non-
acute senescent cells or less efficient elimination of senescent cells by an age 
ageing immune system (Shaw et al. 2010; Childs et al. 2014; Nikolich-Žugich 
2014) (Fig.15). Senescence is a cancer-protective and tumour-suppressive 
mechanism but can in some cases have the opposite effect and promote 
cancer through senescence-associated secretory phenotype (SASP) which 
maintain inflammation (Campisi 2013; Hoare & Narita 2013) (Fig.16). The 
results of SASP are the reverse differentiation of epithelial into mesenchymal-
like cells (epithelial to mesenchymal transition), microenvironmental changes 
and angiogenesis (Bavik et al. 2006; Parrinello 2005) (Fig.16).                                            
Fig.15: Impact of senescence in young and old tissue (López-
Otín et al. 2013). With permission from Elsevier. 
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 1.4.2.2   Senescence in human epithelial cells 
The senescence 
program is activated 
when a critical level of 
DNA damage is 
surpassed, and is 
implemented by TP53 
or CDKN2A/p16 
preventing entry into 




Retinoblastoma (Rb) (Benz 2008). 
This inhibition is reversible upon 
DNA damage repair and is the dominant mechanism of senescence in human 
fibroblasts, astrocytes, keratinocytes and all murine cells. In general, 
mesenchymal-like cells demonstrate more DNA damage at stress-associated 
senescence (stasis) than do human epithelial cells. Stasis is the first of two 
steps that needs to be bypassed in order for cells to become immortal, which 
means they can divide an indefinite number of times (Olsen et al. 2002; Garbe 
et al. 2014). It is telomere independent, but is in similarity to agonescence 
characterized by vacuoled cells and β-galactosidase expression. Stasis is 
induced by DNA damage, oxidative stress etc. in contrast to agonescence, a 
type of senescence specifically induced by critically short telomeres. Human 
epithelial cells show evidence of a TP53 independent induction of stasis. In 
fact, neither TP53 nor CDKN2A/p16 Ink4A is required to induce stasis in human 
mammary epithelial cells (Olsen et al. 2002). Congruently, most mammary 
cancers still express wild type TP53 (Shachney & Silverman 2003). 
Could the changes listed above can explain why ageing cells are more likely to 
develop into tumour cells.  
Fig.16 SASPs have both tumour-suppressive and tumour- 
promoting consequences (Fumagalli & d’Adda di Fagagna 
2009). With permission from Nature Publishing Group.                               
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1.5  Microenvironmental link between Ageing and Cancer   
The common explanation 
for the increased 
incidence of cancer with 
increased age has been 
accumulation of sporadic 
mutations with time, the 
assumption being that 
when the number of 
oncogenes in the cell 
reaches a threshold, 
tumours will develop 
(Campbell et al. 2015; 
Vogelstein & Kinzler 1993). Vogelstein argues further that human organs 
demonstrating high numbers of stem cell divisions, are more likely to 
accumulate mutations, and therefore more prone to develop tumours 
compared to other organs (Tomasetti & Vogelstein 2015).  However, several 
cancer types do not increase in direct correlation to age (Armitage, P;Doll 
1954). Breast cancer incidence peaks at age 50 and then again around age 
70, after which it decreases (Anderson et al. 2014). Most pre-malignant 
mutations occur before the age of twenty, and increase only slightly from then 
on (Degregori 2013) (Fig.17). Indeed, many of these mutations do not result in 
clinical cancer: 36% of people between the age of 50 and 70 years that died of 
non-cancer causes had detectable carcinomas in 2.5mm autopsy cross 
sections (Harach et al. 1985). In sum, the above imply that there is most likely 
a contextual parameter involved in age-related cancer in addition to the 
presence of mutations. Can this parameter, or the consequences of it, be 
detected through functional studies? 
 
1.5.1 Tumour microenvironment versus ageing microenvironment               
The tumour microenvironment shows similarity to the ageing 
Fig.17: Cancer incidence and mutations as a function of age 
(Degregori 2013). With permission from Nature Publishing 
Group   
 33 
 
microenvironment, indicating that the ageing microenvironment may have 
similar influence as a tumour microenvironment - on its residing cells. Here are 
some characteristics to recognize a tumour microenvironment.  A metastatic 
niche and a tumour microenvironment induce malignancy in the residing cells. 
 
1.5.1.1  Extracellular matrix composition and  stiffness promote malignancy 
A stiffer, cross-linked ECM is detected by cells through mechanosensing, 
increased numbers of focal adhesions and reorganization of the cortical actin 
cytoskeleton. This promotes cell migration and is implicated as a “highway” for 
metastatic cells to migrate along (Erler et al. 2006; Snedeker & Gautieri 2014). 
Cells respond to increased local tensile force by assembling focal adhesions, 
and to the relaxation of force by disassembling focal adhesions (Bershadsky et 
al. 2006; Paszek et al. 2009). The composition of the ECM changes during 
tumour development. Collagen I and fibronectin are produced in abundance by 
tumour cells and tumour associated cells (Kaplan et al. 2005; Ioachim et al. 
2002). Tumours have been called: “the wound that never heals”,  as they 
deposit fibronectin in the absence of actual injury (Polyak & Kalluri 2010). 
Hypoxia in the metastatic niche induces lysyl 
oxidase activity via hypoxia-inducible factor-1 
(HIF-1), to form cross-links in collagen I (Erler et 
al. 2006). The deposition of collagen and 
fibronectin, and the crosslinks formed between 
collagen fibrils result in high stiffness in the tumour 
and surrounding stroma (Fig.18). Conversely, 
laminin tends to lack in tumourigenic tissue (Natali 
et al. 1992). These are all phenomena that we 
recognize in the ageing microenvironment, which 
prompts us to ask if the ageing ECM can have 
similar impact. Furthermore, could an ECM of 
lower stiffness rejuvenate old cells placed in it? 
The stiffness and ECM composition of the 
Fig.18 Cell morphology and 
phenotype is instructed by the 
surrounding ECM and its 
rigidity. Adapted from 
(Provenzano et al. 2008) with 





mammary gland stroma 
is calibrated to maintain 
lobule conformation  
allowing lactation 
(Schedin & Keely 2011). 
Tumour development is 
prevented by physically 
forcing the cells into a 
native 3D orientation 
(Bissell et al. 2002; 




associated with ECM 
turnover, processing 
and orientation. These 
changes occur at 
strictly regulated 
timepoints in tissue development and within the menstrual cycle. However, 
with ageing and during tumour development the ECM rearrangement becomes 
extensive and persistent (Schedin 2006).The ECM is no longer fulfilling its 
tumour-suppressive role.  
 
1.5.1.2    Oncogene potential released by the microenvironment 
Dolberg and Bissell demonstrated more than 30 years ago that tumours 
developed when Rous Sarcoma Virus (RSV) was injected into the wing web of 
a hatched chicken, due to the presence of inflammation in the puncture 
wound, while no tumours developed when the virus was put inside a 
developing embryo (Dolberg & Bissell 1984). Even if the genotype for  
 
Fig.19: A malignant phenotype require a malignant microenvironment to 




malignant behavior is present in the cell, we only see the phenotype 
manifested when promoted by changes in the microenvironment (Fig.20). 
Could mutations be suppressed in cells in young tissue, but be promoted by 
the inflammatory microenvironment in the ageing tissue?  Cancer cell lines 
demonstrate malignant phenotype - protrusions, invasion and dissemination -  
in a stromal-like context (collagen I), but not in a context of basement 
membrane-like (laminin and collagen IV) ECM (Egeblad et al. 2010). Further, 
neoplastic cells can revert to a normal phenotype when placed back in stroma 
with stiffness equal to normal healthy breast tissue (Ingber 2008). Chronic 
inflammation in the tissue supplies a series of tumourigenic factors that 
promote cancer-related cellular phenotypes. In addition, inflammatory 
cytokines heavily remodel the non-cellular content of the stroma (López-Nouoa 
& Nieto 2009). Up to 90% of a pancreatic tumour may in fact be non-tumour 
stroma cells, recruited and mobilized in the context of proliferating tumour cells 
(Kong et al. 2012). Signals of tumour origin selectively recruit Th2 CD4 helper 
cells which facilitate tissue repair including angiogenesis, proliferation and anti-
apoptosis (Denardo et al. 2009). Those are all pro-metastatic mechanisms. 
Th1 CD4 helper cells that promote neutralization and killing of tumour cells, on 
the other hand, are suppressed. Cancer is more than a collection of tumour 









Streuli 2013). With 
permission from 
Elsevier.      
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Does the ageing microenvironment demonstrate enough of these tumour-
initiating characteristics to produce tumour cells? 
 
1.5.2  Oncogene induced senescence (OIS)   
Finally, we propose a potential phenotype to be affected by the altered 
microenvironment in the ageing body. Oncogene induced senescence (OIS) is 
the first line of defense against cancer (Serrano M, Lin AW, McCurrach ME, 
Beach D 1997). This intrinsic mechanism serves to remove potentially 
oncogenic cells before they develop into tumours (Fig. 21). When an 
oncogene such as mutated Ras, Raf1 or EGFR is introduced into primary cells 
they do not become immortalized or tumourigenic. Most likely they go into 
senescence, followed by removal by NK cells (Childs et al. 2014). Could a loss 
of this mechanism make cells more prone to develop into tumour cells, and if 
so how does a cell lose this defence?  An oncogene that introduces sustained 
mitogenic stimulation (MAPKinase signaling) triggers senescence, which is 
known as OIS. OIS involves overexcretion of GM-CSF, IL-6,-7.-8, -1β, G-CSF 
and INFγ;  inflammatory factors that are less prominent in senescence induced 
by replicative exhaustion, γ-radiation, oxidative stress or extensive changes in 
chromatin structure (Nelson et al. 2014; Coppé et al. 2010).  Moreover, 
CDKN2A/p16 induces OIS without SASP 
(Fig. 16), due to other signaling pathways 
being involved compared to replicative 
senescence (Adams 2009; Coppé et al. 
2010). Where in the process of 
senescence may the microenvironment 
exert influence?  Is the microenvironment 
necessary and sufficient for tumour cell 
initiation, or does it act in combination 
with other parameters? 
 
Fig.21: Oncogene induced senescence 
(Mallette & Ferbeyre 2007). With permission 
from Taylor & Francis. 
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2. Aims of study 
 
Cancer incidence correlates with age. Post-menopausal women are more prone 
to breast cancer than younger women. The increased frequency of breast 
cancer with age is likely due to interactions between acquired mutations and 
age-dependent changes in the breast tissue microenvironment that affect 
mammary epithelial cells. The central hypothesis of this thesis is that ageing 
affects how human mammary epithelial cells respond to microenvironmental 
signals. To test this hypothesis, we developed a novel microsphere cytometry 
approach to measure microenvironment-contextual cell signaling at the single 
cell level. The overall aim of this project is to better understand the underlying 
mechanisms of age-related breast cancer.  
The specific aims were to: 
• Establish a flow cytometry method (microsphere cytometry) to 
measure ECM-contextual cell signaling in single adherent cells. 
• Employ microsphere cytometry to investigate age-dependent changes 
in signaling responses to the microenvironment. 
• Characterize age-related changes in mammary epithelial cells and 










3. Methodological considerations 
3.1 Cell lines versus low passage primary cells 
Our studies were performed on low passage primary human mammary 
epithelial cells (HMEC). Long term in vitro proliferation results in stress-
associated senescence (stasis). Further, critically short telomeres result in 
telomere dysfunction-associated senescence (agonescence) (Stampfer et al. 
2013). In contrast, cell lines are immortal:  they have successfully bypassed 






Fig.22: Immortalization is a two-step process (Garbe et al. 2014). With permission from Taylor & 
Francis. 
3.1.1  MCF10A cell line does not represent primary human HMEC  
The mammary cell line MCF10A, derived from fibrocystic mammary tissue, is 
frequently used by researchers to represent a normal epithelial cell (Qu 2015, 
Soule 1990). We found culturing of MCF10A cells to be EGF dependent. 
Acinus-like cell aggregates formed in the presence of laminin and the absence 
of EGF (Fig.23a). MCF10A are not known to be tumourigenic in mice. It is of 
luminal descent and forms milk-producing acini in 3D cultures with 
extracellular matrix proteins from the basal membrane (Matrigel) (Fig.23 a). 
However, they simultaneously express basal markers (Qu 2015), and 
demonstrate proliferation as predominant response to laminin, as opposed to 
differentiation (Petersen et al. 1992) (Fig.23a,b). When we employed 
microsphere cytometry to map the signaling signature of MCF10A cells 
compared to HMEC, MCF10A response to stimulation greatly varied from that 
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Fig.23: The MCF10A cell line does not represent primary HMEC (A) Phase contrast photos of cell 
growth in 2D cultures on different extracellular matrix (ECM) proteins revealed that cell morphology, 
but not cell proliferation, was dependent on EGF, on laminin in particular. In the absence of EGF, cells 
distributed themselves into structures similar to acini. Real acini may only form in a 3D substrate. 
Scale bar is 100 µm. (B) Cell proliferation was detected by the conversion of Resazurin into pink 
coloured Resarufin indicating the number of metabolizing cells present as a function of time. Among 
the ECM proteins tested, laminin mobilized the strongest growth, contrary to expectation. Laminin is 
known to direct differentiation at the expense of proliferation. In conclusion, MCF10A cells do not 
behave like primary HMEC. (C) AUC values of graph in (B). (D) Microenvironment-dependent cell 
signaling response patterns in MCF10A cells differs from those in HMEC. pERK and pAKT levels were 
measured longitudinally in HMEC and MCF10A, adhered to collagen, fibronectin or laminin-coated 
microspheres in growth factor supplemented culture medium. MFI (median fluorescence intensity) 
values for pERK (solid lines) and pAKT (dotted lines) plotted as a function of time (0-9 h). MCF10A 
signaling levels did not become normalized within the 9-hour period in comparison to HMEC, but 
remained high throughout. The graph is representative of three independent experiments. 
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of the HMEC (Fig.23d). Consequently, we chose to perform our experiments 
on HMEC rather than on MCF10A cells. 
3.1.2 In vitro culture of Human Mammary Epithelial Cells (HMEC) 
HMEC grow and disperse in cell culture dish from organoids which are 
microscopic tissue pieces - the products of enzymatic and mechanic 
processing of breast tissue following reduction mammoplasties. Samples can 
also be derived from non-tumour mastectomies or suspended cells from 
mother’s milk. Cells are allowed to grow out of individual organoids placed in 
cell culture dishes. Contaminating fibroblasts are removed by partial 
trypsination as described in Paper I (Ertsås et al. 2017). Optimal HMEC growth 
is supported by culture medium M87A (insulin, EGF, estradiol, prolactin, 
somatotropin, thyroid stimulating hormone, adrenocorticotrophic hormone and 
vasopressin) combined with a low concentration of serum, and oxytocin with 
life extending effect (Stampfer 1985; Labarge et al. 2013; Garbe et al. 2009). 
Culture in M87A with oxytocin can support HMEC growth for 16 passages, 
which is equal to 50 population doublings. The biobank at Lawrence Berkeley 
National Laboratory contains HMEC derived from organoids isolated from 50 
women ranging in age from 14 to 91 (hmec.lbl.gov). HMEC used in our studies 
were maximum 4th passage.  
 
Tissue culture of dissociated primary epithelial cells causes a number of 
adaptations, of which the most distorting is the tendency of cells to lose their 
luminal phenotype and become increasingly basal with prolonged in vitro 
culturing (Pechoux 1999). It is particularly important to confirm that the 
phenotypic changes detected in older HMEC are not technical artifacts, but 
indeed of biological nature. Therefore, we measured integrin expression on 
dissociated uncultured epithelial organoids from 9 women and compared these 
to 6th passage HMEC. We found similar integrin expression with age in both 




3.1.3 Selection of EGFR Del19 transformed cells  
Human mammary epithelial cells (HMEC) were 
transformed with vector coupled EGFR with a 
constitutive active kinase activity due to a 
deletion in exon 19 of the EGFR gene. In order 
to select EGFRDel19 transformed cells we 
performed selection by both antibiotics 
(Pyromycin) and by FACS flow. We found that 
either method gave cell populations with equally 
high EGFR expression levels. In conclusion, the 
method of selection is not critical to outcome, 
and HMEC selected by either method can be 








3.2 Isogenic series                                                                                  
In order to investigate changes in signalling response and integrin expression   
during malignant progression, we developed an isogenic transformation series. 
These are cell lines that range from normal to non-malignant immortal and 
finally tumourigenic. Tumourigenic cells are defined as cells capable of 
anchorage-independent growth in a gel like material. Malignant cells do not 
undergo anoikis even when lacking ECM anchorage. Pre-stasis normal cells  
Fig.24 EGFR selection methods.                  
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Fig.25: Two types of senescence that need to be overcome in order for cells to become immortalized 
(Garbe et al. 2014). With permission from Taylor & Francis. 
(passage 3) were transduced with shRNA against CDKN2A/ p16, or 
overexpression of CCND1/CyclinD1 to allow them to bypass stasis by 
preventing Rb activation. CyclinD1 is necessary for self-renewal in mammary 
tissues, and more importantly luminal differentiation into functional lobules and 
ducts (Jeselsohn et al. 2010). 
CyclinD1 overexpression 
promotes transformation into a 
luminal phenotype, and increases 
tolerance to Neu/ERBB2 . 
Suppression of CDKN2A/p16 is 
less likely to give this result (Lee 
et al. 2015). Telomere shortening 
is overcome by ectopic MYC 
expression that induces 
transcription of the telomerase 
reverse transcriptase gene (TERT) (Kyo et 
al. 2008). Flow cytometric measurements 
revealed that myoepithelial or luminal cells 
were transduced with similar efficiency (Fig.26). 
GFP expression level FL1-H 
Fig.26: GFP transduction of luminal and        
myoepithelial cells. Subpopulations present 
immediately after transduction. 
  




Hence, the low fraction of transformed luminal cells found in cell lines after 
prolonged passaging may be related to a myoepithelial-like phenotype, 
acquired post transformation. The isogenic series comprises pre-stasis, 
immortal and malignant human mammary epithelial cells. The genetic 
alterations from one step to the next are known as they were introduced by us  
3.3  Flow cytometry  
Flow Cytometry measures characteristics 
of cell populations at the single cell level, 
such as number, size, DNA content and 
immune phenotype. Cells are stained with 
fluorophore-conjugated antibodies, enter a 
laminar flow and are passed by a laser 
and fluorescence detector (Fig.27). Flow 
cytometry allows analysis of various 
cellular subpopulations within a sample. 
Fluorescence is proportional to the 
number of antibodies bound per cell. The 
median fluorescence of the cell population 
indicates the average number of epitopes 
in each cell. This can be used to calculate the 
percentage of cells demonstrating a change in 
fluorescence in response to a defined treatment. Phospho Flow Cytometry 
measures intracellular phospho-epitopes on signal transduction proteins. 
Microsphere cytometry described in Paper I (Ertsås et al. 2017) allows ECM 
contextual signaling measurement of subpopulations in the sample. 
Microspheres contribute a surface where a microenvironment can be 
mimicked (Fig.28). Each particle comprises both cell and context, and 
signaling is captured as the particles pass by the laser, (Fig.29). Flow 
cytometry is limited by available fluorescence wavelengths and their tendency 
 Fig.27: Abcam.com   
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to bleed into multiple detection channels. Compensation is conducted to 
account for spectral overlap. 
 
 
3.3.1 Challenges of microsphere cytometry 
A particular challenge in microsphere cytometry is avoiding aggregates in the 
sample. Aggregation is promoted by the ECM coating; collagen I-coated 
microspheres tended to clump more than laminin-coated particles . 
Aggregates do not enter the laminar flow and reduce the number of detectable 
events. It was therefore necessary to vortex the sample during analysis, every 
30 seconds. Hence, the microsphere cytometry method requires more cells 
per sample compared to normal flow cytometry without microspheres, due to 
loss of particles during the running step    
Microsphere           cell 
20 μm 
Fig.28: Electronmicroscopy images of a cell binding to a microsphere.                                      
Flowchart of Microsphere Cytometry method (Ertsås et al. 2017). With permission from Royal 




Fig.29: Microsphere cytometry: Microspheres (in 
blue) offer a surface where the microenvironment 
(black threads) can be mimicked. The cell (in 








3.4 Statistical considerations 
Flow cytometry data analysis was performed in Cytobank 
or Flow Jo (Tree Star Inc.), and is presented either as 
colour coded histograms or plotted as sample fluorescence 
as a function of age or time. Fluorescence is presented as 
the log2 ratio of fluorescence post manipulation over pre-
manipulation. Where “pre” is a control sample stained with 
a secondary antibody only (Paper 1 Fig. 2 and 5), or a 
sample were phosphorylation is inhibited (Paper 1 Fig. 3). 
A positive ratio in the histogram is illustrated in yellow and a 
negative ratio in blue (Fig.30).           Fig.30: Histogram                                                                                                             



















































Table 3. Choice of statistical tests 
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4.Summary of papers  
 
Paper I  
Microsphere cytometry to interrogate microenvironment-dependent cell 
signaling 
Henriette Christie Ertsås, Garry P. Nolan, Mark A. LaBarge and James B. Lorens 
Integr.Biol., 2017, 9 (2), pp. 123-134  
 
Microenvironmental cues comprising surface-mediated and soluble factors 
control cellular signaling mechanisms underlying normal cellular responses 
that define homeostatic and diseased cell states. In order to measure cell 
signaling in single adherent cells, we developed a novel microsphere-based 
flow cytometry approach. Single normal or neoplastic cells were adhered to 
uniform microspheres that display mimetic-microenvironments comprising 
surface combinations of extracellular matrix (ECM) proteins in the presence of 
soluble agonists/antagonists. Temporal signaling responses were measured 
with fluorophore-conjugated antibodies that recognize response-dependent 
epitopes by multiparametric flow cytometry. Using this approach, we 
demonstrated that microenvironment-mimetic combinations of growth factors 
and extracellular matrix proteins generate distinct cellular signal networks that 
reveal unique cell signatures in normal and patient biopsy-derived neoplastic 
cells. 
 
Paper II  
Microenvironment-contextual cell signaling is attenuated with age. 
Henriette C. Ertsås, Mark A. LaBarge and James B Lorens  [Manuscript] 
  
Post-menopausal women are more prone to breast cancer than younger women. The 
increased frequency of age-related breast cancers is likely due to interactions 
between mutations and age-dependent epigenetic changes that affect mammary 
epithelial lineage fidelity. We hypothesized that the ageing process fundamentally 
affects how human mammary epithelial cells (HMEC) respond to microenvironmental 
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signals, resulting in increased susceptibility to oncogenic transformation. In order to 
measure microenvironmental cell signaling in normal finite lifespan HMEC, we 
applied a novel microsphere-based flow cytometry technology. Microsphere 
cytometry allows multiparametric single cell quantification of signaling pathway 
activity and lineage-specific marker expression in cells adhered to surface-
functionalized microspheres that mimic specific microenvironments. Using this 
approach, we analyzed age-dependent changes in human mammary myoepithelial 
and luminal epithelial cells exposed to various ECM and growth factors. We found 
that ECM–mediated MAP kinase and PI3 kinase activation levels in HMEC were 
attenuated with age. Older luminal cells displayed higher surface integrin levels 
consistent with acquired basal identity, albeit with decreased integrin phosphorylation 
and increased Src-phosphorylation relative to myoepithelial cells. We show that the 
diminished signaling magnitude in HMEC from older women correlated with reduced 
probability of activating oncogene-induced senescence. We propose that age-related 
alterations in ECM-mediated epithelial cell-regulation may impair protective tumor-




















Increased tumour incidence with age has been suggested to involve an 
attenuation of protective tumour-suppressive functions in the tissue (Fata et al. 
2003; Bissel & Radisky 2001). Researchers propose that the post-reproductive 
microenvironment may select for cells with genetic or epigenetic changes. 
Transformed cells have higher fitness than healthy cells in the ageing body 
(Degregori 2013). These cells may be more efficiently removed during the 
reproductive period of life, but experience a selective advantage during 
ageing. Age-related alterations in immune surveillance facilitate emergent 
cellular phenotypes with altered senescence triggers that tolerate 
inflammation, tissue stiffness and a degraded basal membrane integrity  
(Rozhok et al. 2014)(Paper 2). Luminal mammary epithelial cells with acquired 
basal characteristics that facilitate interaction with different ECM proteins can 
derive a selective advantage in a non-native microenvironment that forms 
following basal membrane degradation. This new landscape favours 
transformed cells over healthy cells, and malignant phenotypes over benign 
(Rozhok et al. 2014). 
Ageing phenotypes are thus the result of both intrinsic factors and extrinsic 
factors in the microenvironment (Hornsby 2002). Hence, we hypothesize that 
age-related microenvironmental changes in the human breast induce 
phenotypic modifications in epithelial cells (Paper 2).  
5.1 Microsphere cytometry to interrogate microenvironment-
dependent cell signaling.    
In order to detect age-dependent phenotypic variations in mammary epithelial 
cells, manifested as cell signaling, we developed the microsphere cytometry 
approach. Microsphere cytometry permits quantification of cell signaling in 
single cells adhered to different ECM proteins. Commonly used methods, such 
as Western blot, can be used to measure protein expression changes in cells 
cultured on tissue culture plates coated with ECM proteins. However, these 
methods represent an average value for the cell population, masking 
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heterogeneity present in the sample (Jensen 2012) and variation in cell 
signaling in cellular subpopulations. Immunofluorescence-approaches can 
reveal subcellular locations of phosphorylated mediators, but throughput is 
low. The use of microspheres to conduct flow cytometry analysis of adherent 
cells was proposed by Bloch et al. more than 30 years ago (Bloch et al. 1983). 
We applied microspheres to quantify cell signaling in different ECM contexts 
that mimic the in vivo microenvironment (Fig.31).  
 
Fig.31: Illustration of ECM coating (in purple) on plastic microspheres. A mimicked microenvironment 
for cells to bind to, Paper I (Ertsås et al. 2017). With permission from Royal Society of Chemistry 
 
Phospho-flow cytometry as a quantitative single-cell methodology offers high 
throughput, but requires that cells are in a suspension (Irish et al. 
2006)(Fig.27).  Single cells bound to 20 µm diameter microspheres coated 
with ECM, are amenable to flow cytometry analysis and treatment with soluble 
factors (Fig.29). Currently we are limited by the physio-chemical attributes of 
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the microspheres. Plastic microspheres are far stiffer than tissues. above 
physiological levels. It is feasible to derive microspheres of uniform diameter 
with varying stiffness using alternative chemistries such as hydrogel based 
microdroplets. Physiologically relevant stiffness in microdroplets can be 
achieved by adjusting the concentration and increasing the crosslinking of 
PEG (poly ethylene glycol) or agarose (Allazetta et al. 2013). Further it is 
feasible to encapsulate cells within agarose to provide a 3D environment for 
individual cells (Hammill et al. 2000). 
 
 
Microdroplets can be made with a diameter between 10 to 100 µm (Fig.32). 
The cell is encapsulated inside the agarose gel droplet of a given stiffness and 
supplemented with different ECM. One Cell Systems™ have the equipment to 
make gel-encapsulated gel droplets in the lab to run on the flow cytometer. A 
microdroplet with ECM embedded in the gel may be less sticky than an ECM 
coated microsphere. Microdroplets could therefore be convenient for use in a 
mass cytometer, with lower risk of clogging the internal capillary of the 
nebulizer.  
5.2. Contextual response of cells in an ageing micro-
environment is attenuated with age    
Our data indicate that human mammary epithelial cells (HMEC) from older 
women have reduced MAPK signaling responses to different ECM (Paper 2 
Fig.1, Suppl. Fig.1). The increase in p(Thr202/Tyr204) ERK level following 
growth factor stimulation was delayed in older HMEC bound to collagen I or 
Fig.32    Scanning Electron Microscopy                 Phase Contrast Microscopy  
               Cell Microsphere (uncoated)                 Gel Microdrop (GMD)  
               (Bloch et al. 1983)                      One Cell Systems 






laminin compared to HMEC derived from younger women (Paper 2 Fig.2). We 
found a significant reduction in p(Tyr1510) levels of the integrin β4 subunit in 
luminal cells (Paper 2 Fig.3c). Integrin β4 influences laminin signal 
transduction, supporting the notion that the laminin-mediated signaling 
associated with HMEC differentiation is diminished with age (Glukhova & 
Streuli 2013; Streuli & Akhtar 2009; Li et al. 2003). Proliferative and migratory 
behaviours supported by fibronectin and collagen I (Carey et al. 2017) are 
similarly downregulated in older HMEC. Notably, the breast basal membrane 
becomes discontinuous with age in part due to hormonal changes during 
menopause (LaBarge et al. 2015; Sympson 1994). Concurrently, collagen I 
and fibronectin deposition increases with age (Schedin & Keely 2011). We did 
not detect significant differences in PI3K-AKT pathway activation in HMEC 
from older versus younger women (Paper 2 Fig.1d). This could relate to the 
observation that adhesion-activated PI3K is largely ECM independent (S. J. 
Yarwood & Woodgett 2001). Other researchers have found greater variation in 
the ECM-induced transcriptome of HMEC within a group of ageing women 
compared to the variation found among a group of young women. This 
suggests a deregulation of gene expression with age (Miyano et al. 2017; Yau 
et al. 2007). Our data confirm a loss of regulation manifested by the lack in 
response to ECM in HMEC derived from ageing women.   
5.3 Attenuated cell signalling responses with age 
5.3.1 Integrin expression and cell adhesion 
Extrinsic factors mediate cell signalling that determine cellular behaviours. 
Contextual ECM information is largely mediated through integrin receptors. We 
therefore asked whether the age-dependent, attenuated, cell signaling was 
correlated with a change in surface expression of integrin, as measured by 
flow cytometry. Surface integrin expression levels were higher on 
myoepithelial than on luminal cells, a ratio that did not differ with age. Luminal 
cells from older women showed increased expression of integrin α6, β4, α2 and 
β1, while α5 and αV remained unchanged (Paper 2 Suppl. Fig.5). These 
 54 
 
findings correspond to previous immunohistochemistry analysis of cartilage 
cells (Shakibaei et al. 1993). The results were consistent for both uncultured 
primary, and HMEC up to passage 5, and showed that integrin expression 
levels were not affected by short term in vitro culturing under our conditions.  
 
We confirmed that the older luminal cells adhered to fibronectin, both 
measured as the absolute number of cells adhered within a 2.5-hour period, 
and as the percentage of adhering cells per minute (Paper 2 Suppl. Fig.4a,b, 
Suppl. Data Fig.1c). This corresponded with higher surface integrin β1 levels 
on older cells (Paper 2 Suppl. Figure 5). Tissue stiffness is likely an age-
dependent factor that influences integrin expression and/or distribution. 
Epithelial cells grown in vitro in a rigid 2D cell culture dish have previously 
demonstrated higher integrin expression compared to cells grown in a 
compliant 3D matrix (Delcommenne & Streulis 1995). Cell invasiveness is 
known to be promoted by higher levels of integrin β1 receptors (Ganguly et al. 
2013; Berry et al. 2003). Increased α6β4 expression found in certain 
carcinomas also correlates with invasive properties (Gordon et al. 2003). 60% 
of primary breast carcinomas show persistent β4 expression (Davis et al. 
2001), and α6 levels are high in several tumours (Ding et al. 2013; Natali et al. 
1992). This contrasts with our findings using isogenic progression series, 
where in fact surface expression of all measured integrins (β1, β4, α6, α2, α5 and 
αV) decreased with increasing malignancy (Suppl. Data Fig.2).  
 
It is paradoxical that HMEC from older women adhere more efficiently to 
fibronectin (through their β1, α5 and αV subunits), but show lower levels of 
adhesion-induced phosphorylated ERK compared to HMEC from younger 
women (Paper 2, Fig.1d right side). This was consistent for all ECM proteins 
tested (Paper 2 Suppl. Fig.1). One explanation may be that integrin dimers can 
be redistributed without altering expression.  During ageing and fibrosis α6β4, 
α5β1 and αvβ3 on luminal cells tend to relocate from the basolateral surface to 
spread into the luminal, lateral and basal surface of the cell (Fig.33) (Ding et 
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al. 2013). For example, when hemidesmosomes disassemble following 
chemotactic stimuli, integrins redistribute to more diffuse F-actin interaction in 
the plasma membrane (Mercurio et al. 2001). Increased tissue stiffness is 
associated with reduced integrin β4 polarity (Paszek et al. 2005; Ding et al. 
2013). The depolarisation and spread of α6β4 throughout the membrane 
facilitates detachment from the substrate and subsequent migration (Natali et 
al. 1992; Stewart & O’Connor 2015). Interestingly, integrin α6 is reported to be 
tumour-suppressive when polarized, but to promote a malignant phenotype 
when delocalized (Natali et al. 1992). Flow cytometry analysis of integrin 
expression does not distinguish integrin localization. In conclusion, HMEC 
integrin surface expression levels and cellular adhesion did not correlate with 
MAPK signalling responses in our analysis. 
 
 
Fig.33: Integrin depolarization on 
epithelial cells induces loss of 




5.3.2 Reduced integrin activation with age 
We asked whether the altered ECM-mediated MAPK signaling response in the 
ageing phenotype could be related to changes in integrin activation. Our data 
demonstrate that activated Src pTyr418 and integrin β4 pTyr1510, as well as 
the activated conformation of integrin β1 in myoepithelial cells decreases with 
age (Paper 2 Fig.3bi)). The fraction of integrin β4 pY1510 versus total integrin 
β4 is reduced in luminal cells from older women (Paper 2 Fig.3c), indicating 
reduced integrin β4 activation, in spite of overall higher surface integrin levels. 
Tyrosine residues on β4 are thought to be substrates for the Scr family kinase, 
Fyn (Mariotti et al. 2001). Thus, the observed attenuated ECM-induced MAPK 
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signaling in older human mammary epithelial cells is likely not due to lower 
integrin levels or reduced adhesion, but rather to integrin redistribution and 
reduced phosphorylation by Scr family kinases.   
5.4 Extracellular matrix and Integrins play a role in oncogene 
induced senescence  
5.4.1 Mechanotransduction is affected by age 
Integrin-mediated cell signalling is suggested to fine-tune growth factor 
receptor signal transduction (Morse, Brahme & D. a. Calderwood 2014). This 
ensures that ECM context in the microenvironment can influence growth factor 
cell signaling characteristics (Giancotti & Tarone 2003; Legate et al. 2009), 
such as survival through the PI3K pathway, proliferation through the MAP 
kinase pathways or cytoskeletal tension via ERK – Rho pathway (Kass et al. 
2007; Levental et al. 2009). The MAP kinase pathway can drive cell 
senescence when mitogenic overload induces a DNA damage response and 
mobilization of tumour suppressors P53 and CDKN2A/p16 (Childs et al. 2015; 
Lin et al. 1998; Di Micco et al. 2006) (OIS see section 1.5.2). Previous studies 
have found an age-dependent effect on the ability of cells to respond to 
stiffness by influencing lineage determination into either myoepithelial or 
luminal phenotype (Pelissier et al. 2014), while we quantified age-dependent 
MAPK pathway activity as the number of phospho-epitopes on ERK. Our 
results indicate that the amplitude and duration of pERK activation in response 
to ectopic expression of a constitutively-active EGFRDel19 is reduced (fig.34 
and fig.35 [orange dotted line]) in older HMEC. This appears to influence cell 
division. HMEC derived from older women grew more slowly in vitro than 
HMEC from younger women. Studies show that it is the cumulative time, 
rather than the frequency of the pERK activation that determines entry into S-





















Fig.34. Schematic model of age-dependent attenuated signaling.  
 
Birtwistle et al 2007 suggested the pre-peak response curve of pERK results 
primarily from EGFR-Ras Raf MEK activity, while the post-peak period is 
maintained via PI3K-PIP3-Gab1-Grb2-SOS-Ras activity (Birtwistle et al. 2007). 
However, pERK is involved in many negative feedback loops; this is consistent 
with our data showing normalized pERK levels within 2 hours after stimulation 
in younger HMEC (Paper 2, Suppl. Fig. 3b). Sustained pERK stimulation is 
required to trigger OIS (Lin et al. 1998). This might be due to the integration of 
several signaling inputs or a single constitutively active input such as mutant 
EGFR  
 
Combined integrin and growth factor signaling form a sigmoidal response 
through an “AND” gate. An example of a response through an “AND” gate is a 
feed forward reaction comprising two or more pathways that converge on a 
node. They may have different kinetics, but both must be activated for the 
converging node to be triggered. Output varies depending on whether it is one, 
the other, or both branches that are activated (Alon 2007; Dueber et al. 2007). 
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For example, different phosphorylated tyrosines on receptor tyrosine kinase 
domains that recruit cognate SH2-signaling proteins signal can converge on a 
downstream signalling node; thus a phosphorylation threshold must be 
surmounted to trigger a downstream signalling event (Giancotti & Tarone 
2003). Integrins also contribute to downstream signalling that could trigger or 
inhibit alternative signaling pathways (Moro et al. 1998; Balanis et al. 2011; 
Danen et al. 2005; Huveneers & Danen 2009). The converging nodes include 
Src, Shc, RhoA, FAK and Rac (section 1.3.4 Fig.12). The attenuated ECM 
response found in older HMEC can consequently be due to attenuated integrin 
signaling as we did not observe a significant effect on growth factor signaling 
(Paper 2 Suppl. Fig.2b)  
 
 5.4.2  The tumour-suppressive function of senescence is lost with age 
Senescence is a hallmark of ageing. The fraction of senescent cells is higher 
in the ageing body (Dimri 1995, Faragher 2017). Paradoxically, our data 
suggest that older HMEC are resistant to oncogene induced senescence 
introduced by EGFRDel19 with constitutive active kinase activity. (Paper 2 
Fig.4). The mitogenic overload following the introduction of the Ras oncogene 
will in most cases lead to cell cycle arrest (A. Kilbey*, A. Terry, E.R. Cameron 
2008). In our study, HMEC derived from postmenopausal women 
demonstrated tolerance to constitutive active EGFR, proliferating for several 
passages in vitro (Paper 2 Fig.4c, Suppl. Data Fig.3a). In contrast, younger 
HMEC expressing EGFRDel19 became enlarged, displayed vacuoles, 
expressed β-galactosidase and stopped proliferating (Paper 2 Fig. 4, Suppl. 
Data Fig. 3b). In vivo they would eventually be removed by the innate immune 
system (Shaw et al. 2010). This suggests that HMEC from postmenopausal 
may be less likely to activate senescence in response to oncogenic EGFR due 
to attenuated signal transduction comprising slower kinetics and a lower 
overall amplitude. EGFR Del19 induced pERK and pAKT levels were different in 
older and younger HMEC, in spite of similar EGFR expression levels (Paper 2 
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Suppl. Fig.6). HMEC selected by antibiotics expressed similar high EGFR 
levels as flow cytometry sorted HMEC (Fig.24). 
 Fig.35:  Schematic model of the signaling intensity level necessary to induce OIS                             
 
It has been shown that MAPK pathway activation must transcend a threshold 
for a certain amount of time in order to induce senescence via TP53 (Olsen et 
al. 2002). We suggest that mitogenic overactivation in older HMEC does not 
transcend this threshold and therefore do not mobilize TP53 (Fig.35 [orange 
line]). The cell continues to live (Suppl. Data Fig.3a). The ageing 
microenvironment may limit MAPK and PI3K activity, and hence reduce OIS 
triggering (Paper 2 Fig.1, Fig.2, Suppl. Fig.3).  A similar correlation between 
loss of mTOR activity and increased lifespan of the nematode C. Elegans was 
previously reported (Vellai et al. 2003; Lamming et al. 2013). Resistance to 
OIS could increase the likelihood of accumulating oncogenic and epigenetic 




5.5 Ageing luminal cells exhibit basal-like traits  
It is previously shown 
that the proportion of 
luminal cells increases 
in ageing mammary 
tissue, while 
myoepithelial cells 
decrease (Garbe et al. 
2012) (Fig.36). 
Normally, luminal cells 
undergo frequent cell 
division during the 
menstrual cycle and pregnancy, 
while myoepithelial cells have a 
lower turnover (Clarke et al. 
2005). However, luminal cells 
from older breast tissue differ. In vivo samples from ageing women 
demonstrate that luminal MUC-1 (CD227+) cells express lower levels of 
cytokeratin 19, another common luminal marker. Certain MUC-1 cells are 
entirely negative for K19 (Garbe et al. 2012).  
 
We found increased basal characteristics in luminal cells from older women. 
Normally, luminal cells express less than half the level of integrins compared 
to myoepithelial cells (Paper 2, Suppl. Fig.5b). Longitudinal monitoring of cell 
adhesion to laminin showed that myoepithelial cells generally adhere faster 
and at higher percentages than luminal cells (Suppl. Data Fig.1b). Secondly, 
luminal cells generally proved to be more responsive to fibronectin - measured 
as the level of phospho-epitopes of AKT-  than myoepithelial cells (Suppl. Data 
Fig.4). In contrast, myoepithelial cells were more responsive to EGF 
stimulation, as measured by pAKT levels (Suppl. Data Fig.4), consistent with a 
higher level of EGF receptors (Colemann et al. 1988). This finding is congruent 
Fig.36: Myoepithelial and luminal epithelial cell fraction as a 
function of age  (Garbe et al. 2012)     
P= peripheral non-tumour mastectomy tissue  
RM= reduction mammoplasty tissue. With permission from 
American Association for Cancer Research.  
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with myoepithelial cells interfacing the basement membrane, while luminal 
cells reside in a microenvironment created entirely by homo- and heterotypic 
cell-cell interactions with myoepithelial cells (Adriance et al. 2005; Deugnier et 
al. 2002). Myoepithelial cells are hence responsible for conveying information 
from the matrix to the luminal cells (Gudjonsson et al. 2005).  
 
Our data shows that only luminal cells from older women demonstrated a 
significant increase in integrin expression of subunit α2, α6, β1 and β4, which 
could reflect exposure to new extracellular matrix contexts (Paper 2 Suppl. 
Fig.5b,d). As a woman ages, basement membrane integrity is degraded and 
the number of myoepithelial cells is reduced (Fig.36), increasing the likelihood 
for luminal cells to be exposed to new matrix proteins (Deugnier et al. 2002). 
The loss in total myoepithelial cells and structural alterations in the basement 
membrane favour luminal cells with basal traits that can benefit from ECM 
interactions (Warburton et al. 1981; Gudjonsson et al. 2005).  
 
Congruent with Garbe et al. we further discovered an age-dependent increase 
in luminal progenitor cells among the human mammary epithelial cells (Suppl. 
Data Fig.5). LaBarge et al. reported that fate decisions of epithelial progenitors 
are regulated by specific microenvironmental features, in particular laminin that 
induces quiescence and impairs differentiation (LaBarge et al. 2009).  As the 
laminin and collagen IV rich mammary basement membrane disintegrates with 
age  (Amano 2009; Sympson 1994), progenitor differentiation into luminal or 
myoepithelial lineage is affected. Age-dependent gene silencing is found to 
particularly target those promoters which maintain stem cell differentiation. 
Thus, the residing cells in ageing tissue might therefore not be able to become 
differentiated (Teschendorff et al. 2010). cKit+ mammary progenitors from 
postmenopausal women fail to differentiate into either luminal or myoepithelial 
lineage, instead retaining expression of both K14 and K19 (Garbe et al. 2012). 
Mammary epithelial progenitors have demonstrated an age-dependent loss of 
response to stiffness variations, where the progenitor cells of the ageing 
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phenotype differentiate into luminal cells regardless of substratum stiffness 
(Pelissier et al. 2014). This is in line with our findings of older luminal cells with 
increased basal characteristics including increased adhesive properties 
(Suppl. Data Fig.1b-e), increased integrin expression (Paper 2, Suppl. 
Fig.5b,d) and lower response to ECM (Paper 2 Fig.1d, Suppl. Data Fig.4) as 
mentioned above. Our data and that of Garbe et al. 2012 show an increasing 
fraction of cells in the ageing mammary gland retaining both luminal and basal 
characteristics. The altered nature of ageing mammary cells promote 
involution (Milanese et al. 2006); the ageing mammary gland is no longer able 
to produce milk nor facilitate contraction of the lobule. The older HMEC does 
not become fully differentiated or undergo epigenetic changes related to 
epithelial to mesenchymal transition (EMT) (Teschendorff et al. 2010). Indeed, 
the ageing microenvironment is associated with inflammation, fibrosis, 
increased stiffness, oxidative stress and loss of immune function (see section 
1.4.1) - all factors known to promote EMT (Cox & Erler 2014; Nieto 2013; 
Thiery et al. 2009).  
Thus, luminal cells may acquire basal-like traits via different mechanisms such 
as skewed differentiation or EMT. This is supported by the fact that HMEC 
from older women demonstrate methylation patterns associated with retained 
stem cell characteristics (Widschwendter et al. 2007). Different lines of 
evidence suggest that luminal progenitor cells are the cell-of-origin for breast 
cancer. BRCA1 mutants have been found to give rise to immature epithelial 
cells with basal differentiation characteristics and basal tumours assumed to 
be of basal origin. However, emerging data assert that they originate from 
luminal progenitors, and that these luminal progenitors are prone to survive 
oncogenic transformation due to their basal-like traits (Choudhury et al., 2013; 
Lim et al., 2009; Molyneux et al., 2010; Proia et al., 2011). It might be a similar 
mechanism acting in progenitors residing in ageing tissue, that cause them to 
develop into luminal cells with basal traits. We ask whether the undifferentiated 
state unveiled in mammary luminal cells in post-menopausal women is the 
feature that makes them more prone to develop into cancer cells. 
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5.6 Ageing and immortalization: Shared traits? 
In considering how ageing HMEC avoid OIS, it is useful to consider cells 
immortalized in vitro which appear to share the trait. Previous studies suggest 
that low-level oncogene expression is the reason that immortalized HMEC do 
not undergo OIS following oncogenic transformation, while finite lifespan 
HMEC become senescent (Olsen et al. 2002). Olsen et al. found no β-
galactosidase activity, and TP53 or CDKN2A/p16 did not need to be 
inactivated in order for benzo(a)pyrene immortalized cells to survive in the 
presence of the Raf-1 oncogene. The immortalized HMEC evaded growth 
arrest by maintaining Raf-1 expression, and the downstream pERK levels, low 
(Olsen et al. 2002). We found an attenuated cell response in immortalized 
HMEC (overexpressing constitutive CCND1/Cyclin D1 and MYC) compared to 
isogenic cells with a finite lifespan (Suppl. Data Fig.7). The mitogenic signal 
resulting from transformation of the Cyclin D1/ MYC immortalized cells with the 
oncogene Neu/ERBB2 was insufficient to trigger OIS. The cells survived 
(Section 3.2 Fig.25) in spite of CDKN2A/p16, TP53 or other tumour-
suppressive mechanisms (Stampfer et al. 2013; Lin et al. 1998). It has been 
suggested that immortalization suppresses mitogenic activation (Stampfer et 
al. 2013), our data suggest that the process of ageing has similar effect on 
HMEC. 
Interestingly, immortalization by overexpression of CCND1/Cyclin D1 rather 
than CDKN2A/p16  inhibition gave rise to a subpopulation of luminal cells, 
which was not found among CDKN2A/p16 inhibited cells (Suppl. Data Fig.6). 
Moreover, Lee et. al. 2015 demonstrated a larger population of luminal cells in 
CCND1/Cyclin D1 immortalized cells from postmenopausal cells, compared to 
premenopausal cells. Postmenopausal CCND1/Cyclin D1 immortalized cells 
comprised cells expressing a mix of both luminal and basal markers, while 
premenopausal CCND1/Cyclin D1 immortalized cells formed cells which were 
mainly negative for the luminal marker CD227 and positive for the basal 
marker CD10 (Lee et al. 2015). This could indicate that alterations in signaling 
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in older HMEC may give different results upon oncogene expression. We can 
only speculate whether suppression of the cell cycle regulators CCND1/Cyclin 
D1 is linked to the higher prevalence of luminal breast cancers in ageing 
women.  
 
5.7 Do OIS resistant cells eventually succumb to agonescence? 
Overcoming stress-associated-arrest (stasis) and agonescence by 
CDKN2A/p16 silencing, CCND1/Cyclin D1 overexpression and telomerase 
reactivation leads to immortalization (Section 3.2 Fig.25). Stasis is the type of 
senescence related to stress, including mitogenic overload, while 
agonescence is the type of senescence related to telomere shortening 
(Stampfer et al. 2013). Agonescence comprises certain viable cells, and is 
reversible in contrast to crisis that entails full blown cell death (Garbe et al. 
2007). p53 suppression is not required for HMEC to bypass stasis, 
agonescence, or to evade OIS. This is in contrast to human keratinocytes and 
fibroblasts, as well as murine cells in general, which are comparably more 
vulnerable to DNA damage and stress mediated by TP53 - they transform 
more easily than human epithelial cells (Stampfer et al. 2013; Adams 2009). 
Fibroblasts with repressed tumour suppressor gene TP53 allow senescent 
cells to re-enter the cell cycle, but this does not occur in HMEC once 
CDKN2A/p16 is activated (Beauséjour et al. 2003). The CDKN2A/p16 
promoter is methylated in spontaneously immortalized cell lines leading to 
lower transcription levels. CDKN2A/p16 promoter methylation is also 
detectable in human breast tissues (Novak et al. 2009). If CDKN2A/p16 
expression is impaired in older HMEC, senescence, but not agonescence, will 
be affected. Senescence appeared reversible in older HMEC compared to 
young HMEC (Suppl. Data Fig.3b). This could account for the lesser degree of 
immediate OIS in older HMEC. Neither cell type displayed anchorage-
independent growth (data not shown). However, when telomeres eventually 
become critically short, even OIS-tolerant older HMEC will undergo 
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agonescence. Our data demonstrate that HMEC from young women senesced 
upon EGFR Del19 overexpression, while HMEC from ageing women continue 
proliferating (Suppl. Data Fig.3a). In other words, EGFRDel19 transformed older 
cells were not immortalized, as they did eventually go into agonescence, with 
the exception of two cases. EGFRDel19 expression in HMEC derived from an 
80-year-old woman were cultured more than 19 passages; cryopreservered 
cells further re-established cell growth.  Supplemental functional studies are 
needed to confirm whether the HMEC have become immortalized.  
In conclusion, a majority of the HMEC from postmenopausal women analysed 
demonstrated prolonged growth upon ectopic expression of the EGFR Del19 
oncogene, but they remain sensitive to telomere shortening. Hence full 
transformation can be, at least theoretically, accomplished with additional 
genetic changes. 
 
6.  Concluding remarks 
60% of all cancer cases in US are diagnosed in people over the age of 65 
(Berger et al. 2006), but there is no consensus to how ageing increases 
cancer susceptibility beyond a simple accumulation of genetic changes. We 
found that HMEC derived from older women show increased basal traits, 
altered signal transduction in response to extracellular matrix proteins and 
evidence of reduced senescence following oncogene expression.  We suggest 
that this is the result of epigenetic changes imposed on HMEC by an age-
related attenuation of the tissue microenvironment (Hashizume et al. 2015).  
This may lead to increased susceptibility to breast cancer with age.  
 
7. Future perspectives  
7.1 Epigenetic modulations as targets for cancer treatment 
Age-dependent deregulation of gene expression and signaling can be a result 
of the increased DNA methylation in regions containing CpG islands combined 
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with a decrease in overall DNA methylation (Weidner et al. 2014; Christensen 
et al. 2009). Methylation of CpG islands in promoters silence gene expression 
(Jones et al. 2015; Lam et al. 2012). The notion that cancer susceptibility 
increases with age due to these epigenetic changes suggests that drugs 
targeting epigenetic mechanisms can be used as cancer chemoprotective 
agents. 
The cancer-preventive effect of demethylating drugs has been demonstrated 
in mouse models and individuals with higher cancer risk due to lifestyle or age 
(Issa 2008). Considering that age-dependent gene silencing is skewed 
towards genes that govern development and maintain differentiation (Boland 
et al. 2014; Teschendorff et al. 2013), could epigenetic targeted therapy block 
tumourigenesis by reviving silenced tumour-suppressor genes such as 
CDKN2A/p16, p21Cip1/Waf1/Sdi1 and TP53? As stated by Azad et al: “Reverting 
the software package of epigenetic abnormalities should be easier than 
repairing the hard drive that harbours the upstream mutations” (Azad 2013). In 
addition to being a target for treatment, age-related epigenetic signatures can 
be useful biomarkers of increased cancer susceptibility, exemplified by 
hypermethylation of CpG islands in promoters predicting future tumour risk 
(Teshcendorff 2013). 
 
7.2 Adjustments to experimental set-up  
Anderson et al. demonstrated in 2014 that breast cancer risk does not 
increase with age in a linear manner (Fig.37)(Anderson et al. 2014). There is a 
peak at 50 and 70 years, after which cancer risk declines. A similar peak is 
found around the age of 80 for all cancers in general, among both genders 
(Pavlidis et al. 2012). These peaks in cancer risk are reflected in our data and 
might have contributed to the observed lack of significant correlation between 
age and response to growth factor stimulation, in particular. Two out of 10 
individuals in our study were older than 70, and may have confounded our 
results. We did indeed see that cell signaling was higher in these 2 individuals 
compared to the other older women (Paper 2 Fig.1d).  Including these 
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individuals in our measurements of growth factor stimulation response as a 
function of age made the calculated correlations non-significant (Paper 2 
Suppl. Fig.2b). In follow-up studies we would like to include more women in 











Fig.37: Incidence of breast cancer subtypes by age (Anderson et al. 2014). With permission from Oxford 
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Fig.1 Cell adhesion efficiency distinguish human mammary cells according to lineage, 
age and immortalization. (A) The percentage of cells adhered to different ECM-coated 
microspheres by 2,5 hours of incubation was plotted as a function of age. HMEC from 10 
women 19-91 y were included. i) Illustration of gating scheme to obtain luminal cells (LEP) 
(CD227+/CD10-) and myoepithelial cells (MEP) (CD227-/CD10+). Side scatter values combined 
with DNA staining distinguish cells from naked microspheres. ii) LEP, iii) MEP and iv) 
progenitor (c-Kit+ /CD227+) cells are presented separately. Significant linear regression 
correlations are marked as solid lines. A significant linear regression correlation between age 
and cell adhesion abilities was found for LEP bound to FN. (B) Cell adhesion kinetics of LEP 
and MEP to FN-coated microspheres was monitored for a period of 9 hours i) Data were fitted 
into a Hill’s curve. Comparison of AUC values of the Hill’s curves demonstrates significant 
difference in cell adhesion between LEP and MEP of ii) all ECM in total iii) and on individual 
ECM. (C) Cell adhesion kinetics of young and old LEP  (19 y, 240L / 72y, 353P) on FN coated 
microspheres. i) Hill’s curve of cell adhesion ii) Comparison of Hill’s coefficients demonstrates 
significant difference in cell adhesion between young and old LEP. (D) Cell adhesion kinetics 
of young and old MEP (19 y, 240L / 72y, 353P) on LAM coated microspheres. i) Hill’s curve of 
cell adhesion.  ii) Comparison of Hill’s coefficients of cell adhesion between young and old 
MEP iii) Comparison of AUC values of the Hill’s curves. We demonstrated significant difference 
in cell adhesion between young and old MEP. (E) Phase-contrast images of young and old 
HMEC illustrating adhesion intensity to different ECM proteins. (F) Cell adhesion kinetics of an 
isogenic HMEC progression series (240L). The series comprised normal i) HMEC (240L), ii) 
immortalized (240LD1MY) and iii) oncogene-transformed (240LD1MYNeu) cells. iv) 
Comparison of AUC values of the Hill’s curves on LAM. The data demonstrate a significant 
decrease in cell adhesion to LAM-coated microspheres with increasing tumourigenicity 
Tukey’s multiple comparisons test confirms significant difference in adhesion between the 
three graphs, p=0,008. (G) Phase-contrast images of the isogenic HMEC progression series 
illustrating adhesion intensity to different ECM, after 24 hours of growth.  (n=3 for each cell 
type). Error bars are ±SD. Scale bars are 100 µm.  Remaining p -values were calculated by 













Fig.2  Integrin expression during cell transformation 
Linear regression analysis of integrin expression on an isogenic human mammary epithelial 
cell progression series (n=3 for each cell line). Significant correlations (P<0.05) are 








































Fig.3 Cell population growth of oncogene transformed cells (EGFR Del19).  
Overexpression of EGFR with a deletion in exon 19, making it constitutively active, leads to 
oncogene induced senescence in cells derived from a younger microenvironment (28, 29 
and 30 y). A) The cells barely survive a couple of population doublings, while cells derived 
from older microenvironments (80, 72, 65 and 58 y) tend to survive a longer period of time. 
Growth is detected from the timepoint that selection of EGFR positive cells is initiated, either 
by flow cytometry sorting or antibiotic selection. B) β-Galactosidase activity in young and old 
cells upon EGFR transduction as they go into senescence. The young cells go into 
senescence within 5 population doubling after EGFR is introduced, ageing cells survive at 
least 18 population doublings before showing signs of growth arrest. Scale bar is 100 µm. 
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Fig.4   Cell activity levels differ between luminal (LEP) and myoepithelial (MEP) cells. 
Comparison of pAKT levels between LEP and MEP. A student t test of grouped data shows 
lower ECM induced signaling in MEP compared to LEP, but higher response to growth factors 
in MEP compared to LEP. This is likely because the low FN- induced signaling level in MEP 
allow for a stronger shift in phospho-level upon growth factor stimulation. LEP are more 
responsive to FN, while MEP save their response until GF stimulated. GMFI = geometric mean 
fluorescent intensity.  * p < 0,05   ** p < 0,01     
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Fig.5  Luminal progenitor (c-Kit+)  population increases with age 
Linear regression analysis of c-Kit positive population among HMEC from 10 women 19-91 





Fig.6 Immortalization by 
overexpressing CCND1/CyclinD1 
results in a luminal subpopulation not obtained when immortalizing through the 
suppression of CDKN2A/p16. Telomer dysfunction was circumvented by overexpressing 
MYC which reactivates telomerase and recuperate telomere length (Kyo 2008).  A control 
population was transduced with a retroviral vector that contained neither shRNA against 
CDKN2A/p16, nor overexpressed CCND1/CyclinD1 or MYC (Kolch 2015). Transduced cells 
that grew beyond the control population were defined as having obtained immortality.  
 
Fig.7 Immortalized cells demonstrate reduced response to ECM and growth factor 
stimulation. Response to solid ECM and soluble growth factors demonstrated as shift in 
phospho-protein levels (pERK and pAKT) upon stimulation. We compared finite life HMEC 
(240L) to immortalized (240LD1MY) cells. Student t-test two tailed unpaired ** p<0,01 MFI = 
mean fluorescent intensity.  
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